BBIO vs ARCC

Comparison between BridgeBio Pharma Inc (BBIO, Company) and Ares Capital Corp (ARCC, Company).

BBIO is from the Healthcare sector, while ARCC is from the Financial Services sector.

5-Year PerformanceARCC has outperformed BBIO, delivering a return of +9.8% compared to +4.3%

BBIO vs ARCC - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BBIO(COMPANY)	ARCC(COMPANY)
Market Cap	$13B	$13B
Max Drawdown	92.80%	84.31%
Sharpe Ratio	1.60	-0.33
5Y Beta	1.08	0.75
Industry	Biotechnology	Asset Management
P/E Ratio	-18.19	11.65
Forward P/E	N/A	9.65
PEG Ratio	-3.24	3.72
Dividend Yield	N/A	10.10%
5Y Dividends CAGR	N/A	3.71%
5Y EPS CAGR	-3.14%	N/A
Debt to Equity	-116.44%	112.68%
Free Cash Flow Yield	-3.31%	-9.15%
P/S Ratio	22.33	4.37
P/B Ratio	123.68	0.97

Market Cap

BBIO

$13B

Winner

ARCC

$13B

Max Drawdown

BBIO

92.80%

Winner

ARCC

84.31%

Sharpe Ratio

Winner

BBIO

1.60

ARCC

-0.33

5Y Beta

BBIO

1.08

Winner

ARCC

0.75

Industry

BBIO

Biotechnology

ARCC

Asset Management

P/E Ratio

Winner

BBIO

-18.19

ARCC

11.65

Forward P/E

BBIO

N/A

ARCC

9.65

PEG Ratio

Winner

BBIO

-3.24

ARCC

3.72

Dividend Yield

BBIO

N/A

ARCC

10.10%

5Y Dividends CAGR

BBIO

N/A

ARCC

3.71%

5Y EPS CAGR

BBIO

-3.14%

ARCC

N/A

Debt to Equity

Winner

BBIO

-116.44%

ARCC

112.68%

Free Cash Flow Yield

Winner

BBIO

-3.31%

ARCC

-9.15%

P/S Ratio

BBIO

22.33

Winner

ARCC

4.37

P/B Ratio

BBIO

123.68

Winner

ARCC

0.97

BBIO vs ARCC - Historical Returns

Returns include dividend reinvestment.

Period	BBIO	ARCC
1 month	-14.89%	-0.37%
3 months	-12.12%	+0.20%
6 months	-0.39%	-1.70%
1 year	+96.00%	-4.17%
5 years(CAGR)	+4.27%	+9.80%
10 years(CAGR)	N/A	+12.29%
Max(CAGR)	+13.57%	+12.00%

BBIO

-14.89%

Winner

ARCC

-0.37%

BBIO

-12.12%

Winner

ARCC

+0.20%

Winner

BBIO

-0.39%

ARCC

-1.70%

Winner

BBIO

+96.00%

ARCC

-4.17%

5Y(CAGR)

BBIO

+4.27%

Winner

ARCC

+9.80%

10Y(CAGR)

BBIO

N/A

ARCC

+12.29%

Max(CAGR)

Winner

BBIO

+13.57%

ARCC

+12.00%

BBIO vs ARCC - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	BBIO	ARCC
2026	-15.47%	-5.05%
2025	+171.24%	-0.34%
2024	-32.16%	+19.80%
2023	+463.04%	+19.29%
2022	-55.59%	-3.00%
2021	-73.79%	+39.31%
2020	+114.06%	+0.59%
2019	+27.22%	+32.01%
2018	N/A	+7.42%
2017	N/A	+4.97%
2016	N/A	+26.10%
2015	N/A	-0.64%
2014	N/A	-2.84%
2013	N/A	+9.64%
2012	N/A	+23.43%
2011	N/A	-0.05%
2010	N/A	+38.30%
2009	N/A	+130.17%
2008	N/A	-47.60%
2007	N/A	-16.31%
2006	N/A	+29.09%
2005	N/A	-7.15%
2004	N/A	+31.40%

BBIO vs ARCC Drawdown Comparison

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The maximum drawdown for ARCC was -79.37%, occurring on Mar 5, 2009. Recovery took 715 trading sessions.

The current BBIO drawdown is -17.24%. The current ARCC drawdown is -12.63%.

Rank	BBIO	ARCC
#1	-92.80% Feb 8, 2021 - Dec 3, 2025	-79.37% Feb 22, 2007 - Dec 22, 2009
#2	-65.45% Dec 23, 2019 - Nov 24, 2020	-56.84% Feb 7, 2020 - Jan 20, 2021
#3	-44.53% Sep 3, 2019 - Nov 20, 2019	-24.60% Apr 29, 2011 - Feb 28, 2012
#4	-21.99% Dec 31, 2020 - Feb 8, 2021	-22.17% Apr 29, 2010 - Sep 29, 2010
#5	-20.25% Jan 22, 2026 - Feb 5, 2026	-21.89% Apr 6, 2015 - Jul 25, 2016
#6	-16.79% Nov 22, 2019 - Dec 9, 2019	-21.78% Apr 20, 2022 - Jul 26, 2023
#7	-14.67% Jul 22, 2019 - Aug 26, 2019	-20.10% Aug 4, 2005 - Sep 27, 2006
#8	-12.87% Jul 11, 2019 - Jul 22, 2019	-19.35% Dec 28, 2004 - Aug 3, 2005
#9	-6.70% Dec 12, 2019 - Dec 18, 2019	-19.33% Jul 17, 2025 - Mar 27, 2026
#10	-6.15% Jan 2, 2026 - Jan 13, 2026	-18.79% Feb 4, 2025 - Jul 10, 2025
#11	-5.62% Jul 5, 2019 - Jul 11, 2019	-17.20% Jan 19, 2010 - Mar 17, 2010
#12	-5.28% Aug 27, 2019 - Sep 3, 2019	-14.28% Nov 9, 2018 - Feb 20, 2019
#13	-4.46% Dec 1, 2020 - Dec 4, 2020	-13.99% Jun 30, 2014 - Feb 23, 2015
#14	-4.45% Dec 18, 2019 - Dec 20, 2019	-11.36% Apr 3, 2012 - Jul 13, 2012
#15	-4.13% Dec 4, 2025 - Dec 12, 2025	-10.76% Feb 8, 2022 - Apr 19, 2022